Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive allogeneic immunotherapy--history and future perspectives.

M Schleuning1

  • 1Med. Klinik III, Universitätsklinikum Grosshadern, Marchiouiuistrasse 15, 81377, Munchen, Germany. mschleu@lrz.uni-muenchen.de

Transfusion Science
|October 18, 2000
PubMed
Summary

Allogeneic stem cell transplants utilize donor lymphocytes for a potent graft-versus-leukemia effect, reducing reliance on intense chemotherapy and irradiation. This advance expands transplant eligibility and offers new strategies for various diseases, though graft-versus-host disease remains a challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Trends of Trait Matching in Avian Frugivory and Its Consequences for the Complementarity and Irreplaceability of Birds.

Ecology letters·2025
Same author

Temporal variation of fungal diversity in a mosaic landscape in Germany.

Studies in mycology·2018
Same author

Sex ratio rather than population size affects genetic diversity in Antennaria dioica.

Plant biology (Stuttgart, Germany)·2018
Same author

A bird pollinator shows positive frequency dependence and constancy of species choice in natural plant communities.

Ecology·2016
Same author

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.

Bone marrow transplantation·2015
Same author

Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.

Leukemia·2013

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) has been a cornerstone for treating hematologic malignancies and bone marrow aplasia for over three decades.
  • Significant advancements include the increased availability of unrelated donors, development of haploidentical transplant regimens, and utilization of G-CSF mobilized peripheral blood stem cells and umbilical cord blood.
  • The introduction of donor lymphocyte infusions (DLI) has revolutionized understanding of transplantation immunology, particularly the graft-versus-leukemia (GVL) or graft-versus-malignancy (GVM) effect.

Purpose of the Study:

  • To re-evaluate the role of myeloablative therapy in allogeneic HSCT.
  • To explore the potential of leveraging the GVL/GVM reaction for disease control.
  • To investigate the feasibility of reduced-intensity conditioning regimens for a broader patient population.

Related Experiment Videos

Main Methods:

  • Analysis of outcomes following the introduction of DLI and GVL/GVM principles.
  • Comparison of conventional myeloablative conditioning with reduced-intensity conditioning regimens.
  • Assessment of eligibility criteria for allogeneic HSCT in elderly patients and those with comorbidities.

Main Results:

  • The graft-versus-leukemia (GVL) or graft-versus-malignancy (GVM) reaction mediated by donor lymphocytes is a potent antileukemic principle, challenging the necessity of myeloablative therapy.
  • Reduced-intensity conditioning regimens, focused on immunosuppression rather than maximal cytoreduction, allow for successful engraftment.
  • This approach has expanded allogeneic HSCT eligibility to elderly patients and those with significant medical comorbidities, and is being explored for solid tumors and autoimmune diseases.

Conclusions:

  • Myeloablative therapy is not essential for long-term disease control in allogeneic HSCT, as the GVL/GVM effect plays a crucial role.
  • Reduced-intensity conditioning broadens the application of allogeneic HSCT to a wider patient demographic.
  • Graft-versus-host disease (GVHD) remains a significant challenge that requires continued research and management strategies.